Fri, November 3, 2017
Thu, November 2, 2017
Wed, November 1, 2017
Tue, October 31, 2017
Mon, October 30, 2017
Fri, October 27, 2017
Thu, October 26, 2017

Derek Archila Maintained (VNDA) at Buy with Increased Target to $26 on, Oct 30th, 2017


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-26-on-oct-30th-2017.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Derek Archila of Oppenheimer, Maintained "Vanda Pharmaceuticals Inc." (VNDA) at Buy with Increased Target from $21 to $26 on, Oct 30th, 2017.

Derek, nor any peers, have made any analyst calls on VNDA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources